Skip to Main Content

22-430 Offer Patients an Added Treatment Option for COVID-19 with Oral Antivirals

Date: 06/09/22

This information applies to Physicians and Participating Physician Groups (PPGs).

PaxlovidTM and LagevrioTM – authorized for emergency use by the U.S. Food and Drug Administration – can be prescribed to treat mild to moderate COVID-19 for use at home.



Last Updated: 06/08/2022